Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial Biotech Investing
Myriad Genetics Submits First Module of Premarket Approval Application to FDA for myChoice® HRD CDx Test Genetics Investing
TetraGenetics and ImmunoPrecise Extend Collaboration With Multi-Target Service Agreement Biotech Investing
Lexaria Bioscience Renews Contracts with Senior Management and Cancels Options Cannabis Investing News
NewLink Genetics Presents Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019 Genetics Investing
Axovant Sciences Announces Pricing of $40 Million Public Offering of Common Shares Genetics Investing